Metlife Inc (NYSE:MET) – Langen Mcalenn boosted their FY2018 earnings per share (EPS) estimates for Metlife in a report released on Tuesday. Langen Mcalenn analyst L. Greenberg now forecasts that the financial services provider will earn $4.95 per share for the year, up from their previous forecast of $4.70.

Several other research analysts also recently commented on the stock. Zacks Investment Research raised shares of Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a report on Thursday, November 9th. ValuEngine downgraded shares of Metlife from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 9th. Sandler O’Neill downgraded shares of Metlife from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Wells Fargo & Co set a $62.00 price target on shares of Metlife and gave the company a “buy” rating in a report on Thursday, December 14th. Finally, Morgan Stanley raised their price target on shares of Metlife from $54.00 to $55.00 and gave the company an “equal weight” rating in a report on Thursday, October 5th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Metlife presently has an average rating of “Hold” and an average target price of $57.77.

Shares of Metlife (MET) traded up $0.70 during trading hours on Thursday, reaching $52.55. 5,947,000 shares of the company’s stock traded hands, compared to its average volume of 5,049,137. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.16 and a current ratio of 0.16. Metlife has a 1 year low of $44.26 and a 1 year high of $55.91. The company has a market cap of $56,210.00, a P/E ratio of 114.24, a price-to-earnings-growth ratio of 1.17 and a beta of 1.49.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.19. The company had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. Metlife’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same period last year, the firm earned $1.28 EPS.

Several institutional investors have recently bought and sold shares of the company. Smithbridge Asset Management Inc. DE raised its position in Metlife by 42.6% in the 4th quarter. Smithbridge Asset Management Inc. DE now owns 42,603 shares of the financial services provider’s stock worth $2,154,000 after purchasing an additional 12,725 shares during the period. Fox Run Management L.L.C. purchased a new position in Metlife in the 4th quarter worth $521,000. Benin Management CORP raised its position in Metlife by 68.4% in the 4th quarter. Benin Management CORP now owns 28,510 shares of the financial services provider’s stock worth $1,442,000 after purchasing an additional 11,585 shares during the period. Cascade Investment Advisors Inc. purchased a new position in Metlife in the 4th quarter worth $948,000. Finally, Cullinan Associates Inc. raised its position in Metlife by 28.6% in the 4th quarter. Cullinan Associates Inc. now owns 115,450 shares of the financial services provider’s stock worth $5,837,000 after purchasing an additional 25,650 shares during the period. Hedge funds and other institutional investors own 76.27% of the company’s stock.

In other news, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the sale, the insider now owns 25,181 shares in the company, valued at approximately $1,367,076.49. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the sale, the insider now owns 49,660 shares in the company, valued at approximately $2,711,436. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Monday, February 5th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.04%. The ex-dividend date of this dividend is Friday, February 2nd. Metlife’s dividend payout ratio (DPR) is currently 347.83%.

ILLEGAL ACTIVITY WARNING: This piece was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2018/01/18/langen-mcalenn-analysts-raise-earnings-estimates-for-metlife-inc-met.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.